Site Editor

Karl D. Lewis, MD

Advertisement

Advertisement

News

Total-Body Skin Examinations to Identify Incidental Skin Cancer

Videos

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib, a Dual SYK/JAK Inhibitor

Medical Literature

Lifestyle Factors Possibly Associated With Non-Melanoma Skin Cancers

Medical Literature

Periauricular Basal Cell Carcinoma: Distribution and Surgical Treatment

Medical Literature

Rare Case of Basal Cell Carcinoma From Tattoo Ink

News

Risk Factors and Behavioral Changes in Basal Cell Carcinoma: Perspective From Romania

Medical Literature

Multimodal Therapeutic Approach to Aggressive Merkel Cell Carcinoma: Case Report

Michael K.K. Wong, MD, PhD, on KRT-232: First-in-Class Agent for Merkel Cell Carcinoma

Theresa M. Medina, MD, on Treating Cutaneous Squamous Cell Carcinoma With Cemiplimab-rwlc

View More

Advertisement

JNCCN Spotlights

Cemiplimab-rwlc (Libtayo^®)

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

View More

More

News

Potential Predictive Markers and/or Therapeutic Targets in Merkel Cell Carcinoma

Chemotherapy Versus Radiotherapy for Merkel Cell Carcinoma

SITC 2020: Cemiplimab for Resistant Metastatic Basal Cell Carcinoma

Case Study Features Rare Primary Merkel Cell Carcinoma Without Skin Involvement

Early Results With Nivolumab Plus Oncolytic Virus in Non-Melanoma Skin Cancers

Seizure Risk and Merkel Cell Carcinoma Metastasis: Case Report

Risk Factors and Behavioral Changes in Basal Cell Carcinoma: Perspective From Romania

Incidence Trends in Cutaneous Squamous Cell Carcinoma in the Netherlands

View More

Advertisement

Published

Medical Literature

Update on Laser Therapies for Basal Cell Carcinoma

Potential Link Between Psoriasis and Risk of Non-Melanoma Skin Cancer

Risk of Internal Malignancies in Patients With Non-Melanoma Skin Cancer

Evaluating Risk of Basal Cell Carcinoma Linked to Solar Ultraviolet Exposure

View More

Ongoing

CE Activities

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

Dana-Farber Cancer Institute

Duke Cancer Institute

View More

Resources

For Your Patients

American Academy of Dermatology

Cancer<em>Care</em>

The Skin Cancer Foundation

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.